ArticleJournal of translational medicine2024

CD19/CD20 dual-targeted chimeric antigen receptor-engineered natural killer cells exhibit improved cytotoxicity against acute lymphoblastic leukemia.

Na Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.